期刊: PROSTATE CANCER AND PROSTATIC DISEASES, ; ()
Background Androgen deprivation therapy (ADT) remains the leading systemic therapy for locally advanced and metastatic prostate cancers (PCa). While a......
期刊: PROSTATE CANCER AND PROSTATIC DISEASES, ; ()
Background Several studies showed that androgen deprivation therapy (ADT) plus local treatment of prostate could improve metastatic prostate cancer (m......
期刊: PROSTATE CANCER AND PROSTATIC DISEASES, ; ()
Background To investigate the role of urine spermine and Spermine Risk Score in prediction of high-grade prostate cancer (HGPCa, ISUP grade group >......
期刊: PROSTATE CANCER AND PROSTATIC DISEASES, 2020; 23 (2)
Background The neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR), as markers of systematic inflammation response, have b......
期刊: PROSTATE CANCER AND PROSTATIC DISEASES, 2020; 23 (1)
Background Lymph node invasion (LNI) is a strong adverse prognostic factor in prostate cancer (PCa). The purpose of this study was to evaluate the rol......
期刊: PROSTATE CANCER AND PROSTATIC DISEASES, 2020; 23 (1)
Background Several randomized control trials (RCTs) have showed that adding either abiraterone acetate (AA) or docetaxel (D) to androgen-deprivation t......
期刊: PROSTATE CANCER AND PROSTATIC DISEASES, 2020; 23 (1)
Background To determine the efficacy and safety of a periprostatic nerve block combined with perineum subcutaneous anaesthesia and intrarectal lidocai......
期刊: PROSTATE CANCER AND PROSTATIC DISEASES, 2020; 23 (1)
Background Patients with inflammatory bowel disease (IBD) are at increased risk of gastrointestinal and extraintestinal malignancies. However, the ass......
期刊: PROSTATE CANCER AND PROSTATIC DISEASES, 2020; 23 (4)
Background Due to the discomfort and incidence of complications increases with the increasing number of biopsy cores, the protocol of prostate biopsy ......
期刊: PROSTATE CANCER AND PROSTATIC DISEASES, 2020; 23 (1)
Backgrounds p53 is a tumor suppressor that prevents cancer onset and progression, and mutations in the p53 gene cause loss of the tumor suppressor fun......
期刊: PROSTATE CANCER AND PROSTATIC DISEASES, 2019; 22 (2)
Background The contemporary active surveillance (AS) criteria may result in an unsatisfactory misclassification rate, which may delay curative treatme......
期刊: PROSTATE CANCER AND PROSTATIC DISEASES, 2019; 22 (4)
Purpose The purpose of this study is to compare the efficacy and safety of transurethral enucleation and resection of prostate for treatment of benign......
期刊: PROSTATE CANCER AND PROSTATIC DISEASES, 2018; 21 (4)
Background Whether the diagnosis of prostate cancer is a contributory psychological stress that causes excess risk of suicide among affected men remai......